Turkey approves China-based Sinovac vaccine's emergency use

published 13.01.2021 17:41

Image of article 'Turkey approves China-based Sinovac vaccine's emergency use'
Share

Turkey had previously also announced that it has agreed to procure 4.5 million doses of the vaccine developed by Pfizer and BioNTech, with an option to procure 30 million more doses later, although President Recep Tayyip Erdogan said on Monday that talks with BioNTech were ongoing.

The first shipment Sinovac vaccine, consisting of 3 million doses, arrived in Turkey late last month.

The Sinovac vaccine underwent studies in Turkey, Brazil and Indonesia, and there's uncertainty over just how protective it is.

ANKARA, Turkey - Turkish authorities gave the go-ahead for the emergency use of the COVID-19 vaccine produced by China’s Sinovac Biotech Ltd. on Wednesday, paving the way for the rollout for Turkey’s vaccination program starting with health care workers and other high-risk groups.

Koca said Turkey's vaccination program would begin on Thursday, starting with health care workers.

Similar Posts